CIMG’s wholly owned subsidiary DZR Tech Limited will acquire 100% of Daren Business Technology by issuing approximately $40 million in company shares held in escrow. The transaction is subject to customary closing conditions and is expected to finalize within 30 days of the February 5 agreement date. The acquisition marks CIMG’s entry into the biopharmaceutical sector, complementing its digital health and sales development business. This diversification strategy aims to leverage Daren’s R&D, production and supply chain capabilities to build a new growth engine and broaden the company’s technology-driven service offerings. The escrowed shares will vest over a 3.5-year assessment period in four tranches tied to audited revenue targets: $29 million for April 1, 2026–September 30, 2026; $71 million for October 1, 2026–September 30, 2027; $143 million for October 1, 2027–September 30, 2028; and $257 million for October 1, 2028–September 30, 2029. Shares will release in phases at 6%, 14%, 28% and 52%, with adjustments or cancellations if targets are not met.